• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Prevention
  • Policy, Organisation and…
  • Adult Immunisation

The Socio-Economic Value of Adult Immunisation Programmes

The Socio-economic Value of Adult Immunisation Programmes
Read more
  • Antimicrobial Resistance (AMR)
  • Policy, Organisation and…
  • Quality of Life

Capturing the Broader Value of Antibiotics

STEDI Roadmap
Read more
  • Health Technology Assessment…
  • Economics of Innovation
  • Innovation

Innovation for Health System Efficiency and Improvement

Report picture
Read more
  • Drug Development/R&D
  • Value, Affordability, and…
  • Value based pricing

Proposals for a Novel UK Antimicrobial Subscription Model: How Will Antibiotic Innovation be Scored?

6
Read more
  • Antimicrobial Resistance (AMR)
  • Value, Affordability, and…

Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective

Proposal for a Novel Antimicrobial  Subscription
Read more
  • Health Care Systems
  • Policy, Organisation and…
  • Economic Evaluation

Reimagining Prevention for a Healthier, More Prosperous Society

Prev web
Read more
  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • Event

OHE at the EuroQol Academy Meeting 2018

OHE’s Patricia Cubi-Molla, Nancy Devlin, Yan Feng, Mike Herdman, Paula Lorgelly, David Mott, David Parkin and Koonal Shah all contributed to the EuroQol Academy Meeting 2018. The third EuroQol Academy Meeting took place between 5th and 7th March in Budapest,…

OHE’s Patricia Cubi-Molla, Nancy Devlin, Yan Feng, Mike Herdman, Paula Lorgelly, David Mott, David Parkin and Koonal Shah all contributed to the EuroQol Academy Meeting 2018.

The third EuroQol Academy Meeting took place between 5th and 7th March in Budapest, Hungary. OHE researchers played an active role in the presentation and discussion of EQ-5D-related research.
 
The EuroQol Group is an international network of experts that initiated and continues to develop the EQ-5D, a generic measure of health outcome. OHE’s Nancy Devlin has co-authored an article on the ‘past, present and future’ of the EuroQol Group and the EQ-5D instrument, featured in a blog post around this time last year.
 
At this year’s Academy Meeting, Nancy Devlin presented on Differences between the 3L and 5L: issues for science, issues for policy. Nancy provided an overview of differences between the three-level and five-level versions of the EQ-5D. Some of the issues were featured in a previous post.
 
The session also featured presentations by:
  • Paula Lorgelly, who presented findings from research comparing EQ-5D-3L and EQ-5D-5L in a cohort of cancer patients;
  • David Mott, who provided an overview of research comparing the performance of the EQ-5D-3L and EQ-5D-5L in a diabetes patient sample;
  • David Parkin (OHE Senior Visiting Fellow), who presented work-in-progress on an EQ-5D-3L/5L simulations laboratory project.
In another session, Koonal Shah summarised the methods and preliminary findings of a mixed methods study seeking to understand what aspects of health and quality of life are important to people. The study complements the ongoing Extending the QALY project (a collaboration between the University of Sheffield, the University of Kent, NICE and OHE), and builds on work recently published in The Patient (an earlier version was published as an OHE Research Paper).
 

Understanding What Aspects of Health and Quality of Life Are Important to People from Office of Health Economics
 
Mike Herdman reprised his role from last year’s Academy Meeting, chairing an ‘Elevator Pitches’ session in which attendees introduced their research ideas with the aim of generating constructive feedback and fostering research collaborations.
 
Results from a study underway in New Zealand, using a new method for generating EQ-5D value sets (based on ‘potentially all pairwise rankings of all possible alternatives’) was reported in a poster by Trudy Sullivan, Sarah Derrett, Paul Hansen and others from the University of Otago together with Nancy Devlin.  
 
For more information about OHE’s programme of EuroQol-related research, please contact Nancy Devlin or Koonal Shah.
 
   
  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Presentations

Related Events

  • Event
  • November 2018

OHE at ISPOR Europe 2018

Read more
  • Event
  • November 2017

OHE at ISPOR’s 20th Annual European Congress: Presentations

Read more
  • Event
  • September 2017

Presentation at the NHS Global Health Volunteering Group Meeting: “The Value of International Volunteering and Placements to the NHS”

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!